AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $818 | +519.7% | 13,269 | +676.9% | 0.01% | +400.0% |
| Q4 2022 | $132 | -100.0% | 1,708 | -87.7% | 0.00% | -75.0% |
| Q3 2022 | $619,000 | +91.0% | 13,862 | +64.0% | 0.01% | +166.7% |
| Q2 2022 | $324,000 | -75.7% | 8,450 | -73.8% | 0.00% | -70.0% |
| Q1 2022 | $1,333,000 | +6.1% | 32,210 | -3.1% | 0.01% | +42.9% |
| Q4 2021 | $1,256,000 | -54.1% | 33,243 | -60.0% | 0.01% | -46.2% |
| Q3 2021 | $2,738,000 | -6.7% | 83,066 | +90.9% | 0.01% | -7.1% |
| Q2 2021 | $2,935,000 | -4.6% | 43,507 | -20.0% | 0.01% | -12.5% |
| Q1 2021 | $3,077,000 | -27.7% | 54,350 | +4.1% | 0.02% | -30.4% |
| Q4 2020 | $4,255,000 | +201.6% | 52,231 | +163.7% | 0.02% | +155.6% |
| Q3 2020 | $1,411,000 | +18.4% | 19,808 | +36.7% | 0.01% | -10.0% |
| Q2 2020 | $1,192,000 | +69.8% | 14,489 | +21.5% | 0.01% | +42.9% |
| Q1 2020 | $702,000 | +34.0% | 11,930 | +135.5% | 0.01% | +40.0% |
| Q4 2019 | $524,000 | +213.8% | 5,066 | -21.8% | 0.01% | +400.0% |
| Q2 2019 | $167,000 | +20.1% | 6,478 | -81.9% | 0.00% | 0.0% |
| Q1 2017 | $139,000 | – | 35,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |